Search Orphan Drug Designations and Approvals
-
Generic Name: | Aldesleukin | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Name: | Proleukin | ||||||||||||||||
Date Designated: | 09/14/1988 | ||||||||||||||||
Orphan Designation: | Treatment of metastatic renal cell carcinoma. | ||||||||||||||||
Orphan Designation Status: | Designated/Approved | ||||||||||||||||
Sponsor: |
Chiron Corporation 4560 Horton Street Emeryville, California 94608 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
1 | Generic Name: | Aldesleukin |
---|---|---|
Trade Name: | Proleukin | |
Marketing Approval Date: | 05/05/1992 | |
Approved Labeled Indication: | Treatment of adults (>18 years old) with metastatic renal cell carcinoma. | |
Exclusivity End Date: | 05/05/1999 | |
Exclusivity Protected Indication* : | ||
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-